Does Influenza Vaccination Benefit Patients Hospitalized With Diabetes?
Does influenza vaccination protect patients hospitalized for diabetes against the risk for poor outcomes and complications?
Does influenza vaccination protect patients hospitalized for diabetes against the risk for poor outcomes and complications?
Researchers assessed the protective effects of influenza vaccination among older adults with cardiovascular disease.
Researchers estimated uptake of the meningococcal A, C, W, Y vaccine among individuals with newly diagnosed HIV infection at increased risk for meningococcal disease.
Dr Robert Popovian discusses access to immunization services among adults in low-income communities and efforts to expand pharmacists’ authority to administer vaccines to increase vaccination rates for this vulnerable population.
A phase 2 study assessed safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine with a mRNA-1273 vaccine booster dose in older adults.
Researchers assessed the rate of recurrent COVID-19 infection among unvaccinated adults previously infected with COVID-19.
The impact of human papillomavirus (HPV) vaccination is increasing in the United States, with evidence of herd protection.
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
As the medical field shifted its priorities to treating COVID-19 at the start of the pandemic, routine immunization was one of the many medical fields to experience disruption. What was the scope of this disruption and what are possible ways to address it?
How effective is the 13-valent pneumococcal conjugate vaccine in preventing pneumonia and lower respiratory tract infection hospitalizations in older adults?